Engineering a versatile lipoMSN delivery platform for the development of gene and drug therapies
The question of delivery has become a critical part of therapeutic research and development. While nanoparticle formulations are now used in a variety of FDA-approved therapies, these focus on simple oral formulations or systemic lipid nanoparticle administration; therefore, significant research is...
| Main Author: | |
|---|---|
| Language: | English |
| Published: |
2020
|
| Subjects: | |
| Online Access: | https://doi.org/10.7916/d8-743w-4z67 |